What is ClearPoint Neuro's debt issuance cost amortization?

ClearPoint Neuro (CLPT) reported debt issuance cost amortization of $42K in Q1 2026.

What is the long-term trend for ClearPoint Neuro's debt issuance cost amortization?

Over 4 years (2021 to 2025), ClearPoint Neuro's debt issuance cost amortization has grown at a -4.6% compound annual growth rate (CAGR), from $100K to $83K.

What does debt issuance cost amortization mean?

Non-cash amortization of capitalized costs incurred to issue debt (underwriting fees, legal costs, SEC filing fees).

ClearPoint Neuro CLPT Debt Issuance Cost Amortization

Debt Issuance Cost Amortization at other companies

Neuropace, Inc.NPCE

$68K+38.8%

Merit Medical SystemsMMSI

$1.41M0.0%

ITG

Integer HoldingsITGR

$1.63M-13.7%

LivaNovaLIVN

$4.77M-16.0%

BrightSpring Health Services, Inc.BTSG

$2.82M+2.4%

Other financials

Income statement

See full

Revenue$12.1M+42.9%

Gross profit$7.8M+51.1%

Operating income-$8.5M-37.6%

Net income-$9.6M-58.5%

EPS (diluted)-$0.32-45.5%

Balance sheet

See full

Cash & equivalents$36.5M+195%

Total debt$63.6M+1,750%

Total equity$18.8M-5.7%

Total assets$93.4M+211%

Cash flow

See full

Operating cash flow-$8.0M-29.1%

CapEx$645.0K+252%

Free cash flow-$8.6M-35.5%

Valuation

See full

Market cap$538.61M+69.2%

Enterprise value$565.68M+82.9%

P/S13.3×+3.4×

Profitability

See full

Gross margin62.3%+1.1pp

Operating margin-65.2%-1.9pp

Net margin-71.6%+8.8pp

FCF margin-65.7%+269pp

Returns & leverage

See full

Return on equity-149.7%+4,074pp

Debt / equity3.4×+3.2×

Current ratio5.8×+2.3×

Where this comes from

Reported directly by ClearPoint Neuro in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfFinancingCostsAndDiscounts.

The official record: ClearPoint Neuro’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about ClearPoint Neuro's debt issuance cost amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ClearPoint Neuro's debt issuance cost amortization?: ClearPoint Neuro (CLPT) reported debt issuance cost amortization of $42K in Q1 2026.
What is the long-term trend for ClearPoint Neuro's debt issuance cost amortization?: Over 4 years (2021 to 2025), ClearPoint Neuro's debt issuance cost amortization has grown at a -4.6% compound annual growth rate (CAGR), from $100K to $83K.
What does debt issuance cost amortization mean?: Non-cash amortization of capitalized costs incurred to issue debt (underwriting fees, legal costs, SEC filing fees).